Nuzenio

Oncodaily Ed Esplin

Oncodaily Ed Esplin entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 4 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Ed Esplin: The Time Is Now for Universal Germline Testing in Prostate Cancer - OncodailyOncodaily · Sat, 08 Aug 2026 23:36:23 GMTEd Esplin: Identifying Lynch Syndrome-Associated PGVs in 3.1% of Unselected UTUC Patients - OncodailyOncodaily · Mon, 03 Aug 2026 17:04:55 GMTJemma S.։ Reducing the Discovery to Practice Gap in Precision Oncology - OncodailyOncodaily · Mon, 27 Jul 2026 11:31:39 GMTEd Esplin: New Data Support Universal Germline Testing in Prostate Cancer - OncodailyOncodaily · Sun, 26 Jul 2026 11:37:14 GMT

Timeline

Sat, 08 Aug 2026 23:36:23 GMTEd Esplin: The Time Is Now for Universal Germline Testing in Prostate Cancer - Oncodaily
Mon, 03 Aug 2026 17:04:55 GMTEd Esplin: Identifying Lynch Syndrome-Associated PGVs in 3.1% of Unselected UTUC Patients - Oncodaily
Mon, 27 Jul 2026 11:31:39 GMTJemma S.։ Reducing the Discovery to Practice Gap in Precision Oncology - Oncodaily
Sun, 26 Jul 2026 11:37:14 GMTEd Esplin: New Data Support Universal Germline Testing in Prostate Cancer - Oncodaily

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Oncodaily Ed Esplin.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.